Clinical Research Directory
Browse clinical research sites, groups, and studies.
Role of Endocrine Disruptors in Thyroid Cancer
Sponsor: Istituto Auxologico Italiano
Summary
the relationship between human exposure to EDCS and TC is poorly investigated and still unclear. The aim of this study is to evaluate the possible role of old and new generation endocrine disruptors in thyroid cancer. The primary aim is to evaluate the difference in the average levels of the main endocrine disruptors (PFAS, including: PFOA, PFOS, PFDA, PFUnA, PFHpS and possibly subsequently other categories, such as bisphenols, phthalates, parabens, PCBs, flame retardants) between patients with and without a diagnosis of thyroid cancer through highly sensitive, selective and precise mass spectrometry methods, such as liquid chromatography combined with tandem mass spectrometry (LC-MS / MS). The secondary aim is to evaluate the relationship between the concentrations of endocrine disruptors and some anamnestic variables studied (for example the type of diet, the use of personal care products).
Official title: Cross-sectional Case-control Study on the Role of Endocrine Disruptors in Thyroid Cancer
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
222
Start Date
2022-07-12
Completion Date
2025-07-31
Last Updated
2024-04-16
Healthy Volunteers
No
Interventions
Blood and urine diagnostic evaluation
Blood and urine samples will be obtained from both case and control groups in order to evaluate EDCs concentrations
Locations (1)
Istituto Auxologico Italiano, IRCCS
Milan, Italy